We are live on
!
Find out more
ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
129 hedge funds and large institutions have $454M invested in Intra-Cellular Therapies Inc. in 2016 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 50 increasing their positions, 26 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
225% more call options, than puts
Call options by funds: $6.09M | Put options by funds: $1.88M
92% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 26
8% more capital invested
Capital invested by funds: $423M → $454M (+$31.8M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 29
2% less funds holding
Funds holding: 131 → 129 (-2)
Holders
129
Holders Change
-2
Holders Change %
-1.53%
% of All Funds
3.23%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
29
Increased
50
Reduced
26
Closed
29
Calls
$6.09M
Puts
$1.88M
Net Calls
+$4.22M
Net Calls Change
+$2.67M
Top Buyers
Top Sellers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$9.14M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
-$5.13M |
| 3 |
SCM
Sarissa Capital Management
Greenwich,
Connecticut
|
-$4.45M |
| 4 |
Jennison Associates
New York
|
-$4.08M |
| 5 |
TCM
TimesSquare Capital Management
New York
|
-$3.13M |
